HCA Health Inc vs iShares MSCI China ETF — how do they compare? HCA Health Inc trades at $410.01 (market cap $89.64B), while iShares MSCI China ETF trades at $55.86. The key difference: HCA Health Inc pays a 0.75% dividend while iShares MSCI China ETF pays none. Which is the better fit depends on your goals.
| HCA | MCHI | |
|---|---|---|
Market Cap | $89.64B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $545.13 | $66.99 |
52-Week Low | $361.32 | $50.48 |
Enterprise Value | $140.18B | — |
Dividend Yield | 0.75% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MCHI trades at $56.57, up 1.19% with strong technical momentum showing bullish moving averages and institutional buying interest. The ETF benefits from China's export strength and AI-driven manufacturing growth, though key financial ratios remain undisclosed. Recent news highlights China's 23% July export surge and $295 billion AI infrastructure plan, creating positive sentiment around Chinese equities.
Outlook remains cautiously optimistic with technical indicators signaling strength but RSI levels suggesting potential overbought conditions. Key risks include US-China trade tensions and regulatory uncertainties, while institutional flows and China's tech investment push provide upside catalysts for continued momentum.
Trailing returns across standard periods
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →